GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SpA (MEX:STVN N) » Definitions » Moat Score

Stevanato Group SpA (MEX:STVN N) Moat Score : 5/10 (As of Jul. 16, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Stevanato Group SpA Moat Score?

Stevanato Group SpA has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Stevanato Group SpA has Narrow Moat: Stevanato Group SpA benefits from a solid narrow moat due to its strong brand in pharmaceutical packaging and manufacturing. It has valuable intellectual property and economies of scale, but lacks significant network effects or regulatory barriers to elevate it to a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Stevanato Group SpA might have Narrow Moat - Solid narrow moat.

Competitive Comparison of Stevanato Group SpA's Moat Score

For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stevanato Group SpA's Moat Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Moat Score distribution charts can be found below:

* The bar in red indicates where Stevanato Group SpA's Moat Score falls into.


;
;

Stevanato Group SpA  (MEX:STVN N) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Stevanato Group SpA Moat Score Related Terms

Thank you for viewing the detailed overview of Stevanato Group SpA's Moat Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Stevanato Group SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SpA (MEX:STVN N) » Definitions » Moat Score
Comparable Companies
RGEN MMSI TFX AVTR NVST ICUI XRAY ATR WRBY LMAT ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 XPAR:DIM OCSE:COLO B XSWX:STMN
Traded in Other Exchanges
STVN:USA 87N:Germany
Address
Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Website
https://www.stevanatogroup.com
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Stevanato Group SpA Headlines

No Headlines